BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology Pharmaceuticals: Streamlined Nonclinical Safety Stu
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-10873-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260731
DTEND;VALUE=DATE:20260801
SUMMARY:FDA comments close: Oncology Pharmaceuticals: Streamlined Nonclini
 cal Safety Studies for Biologics and Conjugated Products\; Draft Guidance
  for Industry\; Availability
DESCRIPTION:Notice. Federal Register 2026-10873. Docket FDA-2026-D-2839. D
 etails: https://docket-clock.pages.dev/doc/2026-10873/ Official: https://
 www.federalregister.gov/documents/2026/06/01/2026-10873/oncology-pharmace
 uticals-streamlined-nonclinical-safety-studies-for-biologics-and-conjugat
 ed
URL:https://www.federalregister.gov/documents/2026/06/01/2026-10873/oncolo
 gy-pharmaceuticals-streamlined-nonclinical-safety-studies-for-biologics-a
 nd-conjugated
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR